GRPR and breast neoplasm: In addition, Mendoza-Nava et al. performed a preclinical study on the development of a 177Lu-labeled dendrimer (PAMAM-G4) conjugated with folate and bombesin, incorporating gold nanoparticles (AuNPs) for the targeted imaging and therapy of breast tumors overexpressing FR and GRPR.